U.S. Food and Drug Administration
Performance Plan
2002

Part 2: Performance Plan and Report

Introduction

Part Two of the Performance Plan presents FY 2002 performance goals and the final FY 2001 performance goals for each of FDA's programs, the performance report for FY 2000 goals, and an update on performance for some FY 1999 goals.

In this section of the Plan, readers will be able to obtain greater detail to support their understanding of the key Performance goals described in Part One.

Each program section includes the following information:

• Total program funding
• A broad description of program activities
• Strategic goals
• Approaches for achieving goals
• A performance goal summary table; and
• A goal-by-goal explanation including some updated FY 1999 results.
• A verification and validation section which addresses sources and quality of data used in the plan.

The following programs will be covered:

• Foods -- Promotes and protects the public health and economic interest by ensuring that the food supply is safe, nutritious, wholesome, and honestly labeled. The program also ensures that cosmetics are safe and properly labeled.
• Human Drugs -- Ensures that all drug products used for the prevention, diagnosis, and treatment of disease are safe and effective; and that information on proper use is available to all users.
• Biologics -- Ensures the safety, potency, and effectiveness of biological products for the prevention, diagnosis, and treatment of disease. This includes blood and blood products, blood test kits, vaccines, therapeutic agents, and other biological products.
• Animal Drugs and Feeds -- Ensures that only safe and effective animal drugs, devices, feeds, and food additives are marketed; and that foods from animals that are administered drugs are safe for human consumption.
• Medical Devices and Radiological Health -- Ensures that medical devices are safe, effective, and properly labeled; and that the public is not exposed to unnecessary radiation from medical, industrial, and consumer products.
• National Center for Toxicological Research -- Conducts scientific research to develop methods for regulatory applications.
• Tobacco -- The Tobacco program worked to reduce young people's use of tobacco through education, enforcement, and partnerships with CDC and other Federal and state health agencies. On August 23, 1996 FDA issued its final regulation on tobacco products. From February 28, 1997 until March 21, 2000, when the Supreme Court ruled, ending the program, FDA enforced the age and photo identification restrictions of the rule. During this time, FDA contracted with all 50 states to conduct nearly 200,000 compliance checks of retailers.

Previous | Table of Contents | Next